Allogene Therapeutics (ALLO) Revenue (2021 - 2024)

Allogene Therapeutics recorded quarterly Revenue of $22000.0 in Q1 2024, up 4.76% quarter-over-quarter from $21000.0 in Q4 2023, and down 26.67% year-over-year from $30000.0 in Q2 2023.

Allogene Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $22000.0 for Q1 2024.

  • In Q1 2024, Revenue fell 26.67% year-over-year to $22000.0; the TTM figure through Dec 2024 stood at $22000.0 (down 76.84% YoY), while the FY2024 annual figure was $22000.0, down 76.84% from the prior year.
  • Revenue came in at $22000.0 for Q1 2024 at Allogene Therapeutics, up from $21000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $75.7 million in Q4 2021 to a low of $21000.0 in Q4 2023.
  • A 4-year average of $8.8 million and a median of $30000.0 in 2023 frame the typical range for Revenue.
  • On a YoY basis, Revenue climbed as much as 45.45% in 2022 and fell as far as 99.97% in 2022.
  • Allogene Therapeutics' Revenue stood at $75.7 million in 2021, then slumped by 99.97% to $26000.0 in 2022, then slipped by 19.23% to $21000.0 in 2023, then increased by 4.76% to $22000.0 in 2024.
  • According to Business Quant data, Revenue over the past three periods registered $22000.0, $21000.0, and $22000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.17 Bn
10 Allogene Therapeutics 521.43 Mn 521.43 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 22,000.00
Dec 31, 2023 21,000.00
Sep 30, 2023 22,000.00
Jun 30, 2023 22,000.00
Mar 31, 2023 30,000.00
Dec 31, 2022 26,000.00
Sep 30, 2022 27,000.00
Jun 30, 2022 64,000.00
Mar 31, 2022 39,000.00
Dec 31, 2021 75.65 Mn
Sep 30, 2021 49,000.00
Jun 30, 2021 44,000.00
Mar 31, 2021 38.35 Mn